|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 415 SEK | -2.67% |
|
-1.61% | +44.40% |
| Jul. 12 | Transcript : Mycronic AB, Q2 2024 Earnings Call, Jul 12, 2024 | |
| Jul. 12 | Mycronic AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 | CI |
Mycronic AB (publ) provided sales guidance for the full year 2024. For the year, Board of Directors adjusts its opinion regarding net sales for 2024, from being at a level of SEK 6.25 billion to being at a level of SEK 6.5 billion.
| 1st Jan change | Capi. | |
|---|---|---|
| +44.40% | 3.85B | |
| +47.01% | 430B | |
| +36.59% | 140B | |
| +41.36% | 104B | |
| +31.48% | 23.57B | |
| +20.56% | 21.78B | |
| +49.95% | 11.3B | |
| +26.60% | 10.37B | |
| +31.14% | 9.62B | |
| +86.74% | 5.85B |
MYCRONIC AB 
